dilevalol has been researched along with bn 52020 in 1 studies
| Studies (dilevalol) | Trials (dilevalol) | Recent Studies (post-2010) (dilevalol) | Studies (bn 52020) | Trials (bn 52020) | Recent Studies (post-2010) (bn 52020) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 14 | 0 | 5 |
| Protein | Taxonomy | dilevalol (IC50) | bn 52020 (IC50) |
|---|---|---|---|
| Glycine receptor subunit alpha-1 | Homo sapiens (human) | 1.8032 | |
| Glycine receptor subunit alpha-2 | Homo sapiens (human) | 2.0476 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 3.8 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 3.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
1 other study(ies) available for dilevalol and bn 52020
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |